We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
6 hedge funds and large institutions have $11.8M invested in Arcturus Therapeutics in 2013 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+6
Holders Change %
–
% of All Funds
0.2%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AWMDMG
1
Austin W. Marxe & David M. Greenhouse
New York
| $4.64M | +$4.74M | +96,676 | New |
|
|
KCM
2
Knoll Capital Management
Miami,
Florida
| $4.02M | +$4.11M | +83,857 | New |
|
3
JP Morgan Chase
New York
| $1.64M | +$1.68M | +34,286 | New |
|
|
ACPU
4
Arrowgrass Capital Partners (US)
Dover,
Delaware
| $1.26M | +$1.29M | +26,292 | New |
|
|
TMC
5
Trellus Management Company
Delray Beach,
Florida
| $274K | +$280K | +5,714 | New |
|
|
U
6
UBS
Zurich,
Switzerland
| $3K | +$2.84K | +58 | New |
|